Figure 2

Microtubule alteration-mediated pVHL subcellular localization trafficking was involved in HIF-1α regulation.
(A) CMs were transfected with recombinant adenovirus to overexpress pVHL (pVHL-Ad) before treatment with paclitaxel prior to hypoxia. Western blots are shown for pVHL and HIF-1α in the total (T), nuclear (N) and cytosolic (C) fractions in hypoxic CMs. (B) The graphs depict the mean ± SD (n = 3) of the relative integrated signal. (C) CMs were transfected with recombinant adenovirus to silence pVHL (pVHL-siRNA) before treatment with colchicine prior to hypoxia. Western blots are shown for pVHL and HIF-1α in the total (T), nuclear (N) and cytosolic (C) fractions in these hypoxic CMs. (D) The graphs depict the mean ± SD (n = 3) of the relative integrated signal. CMs, cardiomyocytes; H, hypoxia; H + T + Vector, hypoxia, paclitaxel and the negative control; H + T + pVHL-Ad, hypoxia, paclitaxel and pVHL overexpression; H + C + Mock, hypoxia and Mock transfection (as a negative control of pVHL-siRNA transfection); H + C + pVHL-siRNA, hypoxia, colchicine and pVHL silencing; *, P < 0.05 versus the H group; #, P < 0.05 versus the H + T + Vector or H + C + Mock group.